Literature DB >> 23687578

Clostridium difficile Infection in Children: Current State and Unanswered Questions.

Pranita D Tamma1, Thomas J Sandora2.   

Abstract

The incidence of Clostridium difficile infection (CDI) in children has increased over the past decade. In recent years, new and intriguing data on pediatric CDI have emerged. Community-onset infections are increasingly recognized, even in children who have not previously received antibiotics. A hypervirulent strain is responsible for up to 20% of pediatric CDI cases. Unique risk factors for CDI in children have been identified. Advances in diagnostic testing strategies, including the use of nucleic acid amplification tests, have raised new questions about the optimal approach to diagnosing CDI in children. Novel therapeutic options are available for adult patients with CDI, raising questions about the use of these agents in children. Updated recommendations about infection prevention and control measures are now available. We summarize these recent developments in pediatric CDI in this review and also highlight remaining knowledge gaps that should be addressed in future research efforts.
© The Author 2012. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clostridium difficile; Diarrhea; Pediatrics; Pseudomembranous colitis; Toxic megacolon

Year:  2012        PMID: 23687578      PMCID: PMC3656539          DOI: 10.1093/jpids/pis071

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  130 in total

1.  Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics.

Authors:  J Yee; C M Dixon; A P McLean; J L Meakins
Journal:  Arch Surg       Date:  1991-02

2.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

3.  In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.

Authors:  T Peláez; L Alcalá; R Alonso; A Martín-López; V García-Arias; M Marín; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Clostridium difficile infection in hospitalized children in the United States.

Authors:  Cade M Nylund; Anthony Goudie; Jose M Garza; Gerry Fairbrother; Mitchell B Cohen
Journal:  Arch Pediatr Adolesc Med       Date:  2011-01-03

5.  Recent trends in the use of antibiotic prophylaxis in pediatric surgery.

Authors:  Shawn J Rangel; Monica Fung; Dionne A Graham; Lin Ma; Caleb P Nelson; Thomas J Sandora
Journal:  J Pediatr Surg       Date:  2011-02       Impact factor: 2.545

6.  Colorectal disease in liver allograft recipients -- a clinicopathological study with follow-up.

Authors:  Newton A C S Wong; Andrew J Bathgate; Christopher O C Bellamy
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 2.566

7.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

8.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

9.  A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.

Authors:  David F Gardiner; Talia Rosenberg; Jerry Zaharatos; David Franco; David D Ho
Journal:  Vaccine       Date:  2009-04-09       Impact factor: 3.641

10.  Reduction of Clostridium Difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods.

Authors:  Brittany C Eckstein; Daniel A Adams; Elizabeth C Eckstein; Agam Rao; Ajay K Sethi; Gopala K Yadavalli; Curtis J Donskey
Journal:  BMC Infect Dis       Date:  2007-06-21       Impact factor: 3.090

View more
  16 in total

1.  Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.

Authors:  Larry K Kociolek; Dale N Gerding; James R Osmolski; Sameer J Patel; David R Snydman; Laura A McDermott; David W Hecht
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey.

Authors:  Larry K Kociolek; Preeta K Kutty; Philip M Polgreen; Susan E Beekmann
Journal:  Infect Control Hosp Epidemiol       Date:  2019-02-15       Impact factor: 3.254

3.  Community-acquired Clostridium difficile infection in Serbian pediatric population.

Authors:  Stojanović Predrag; Kocić Branislava; Stojanović Nikola; Radulovic Niko; Stojanović-Radić Zorica; Dobrila Stanković-Đorđević
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-01       Impact factor: 3.267

4.  Vancomycin Use for Pediatric Clostridium difficile Infection Is Increasing and Associated with Specific Patient Characteristics.

Authors:  Hayden T Schwenk; Dionne A Graham; Tanvi S Sharma; Thomas J Sandora
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

5.  Risk Factors for Community-associated Clostridium difficile-associated Diarrhea in Children.

Authors:  Jonathan D Crews; Lauren R Anderson; D Kim Waller; Michael D Swartz; Hebert L DuPont; Jeffrey R Starke
Journal:  Pediatr Infect Dis J       Date:  2015-09       Impact factor: 2.129

6.  Natural Clostridioides difficile Toxin Immunization in Colonized Infants.

Authors:  Larry K Kociolek; Robyn O Espinosa; Dale N Gerding; Alan R Hauser; Egon A Ozer; Maria Budz; Aakash Balaji; Xinhua Chen; Robert R Tanz; Nazli Yalcinkaya; Margaret E Conner; Tor Savidge; Ciaran P Kelly
Journal:  Clin Infect Dis       Date:  2020-05-06       Impact factor: 9.079

7.  Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis.

Authors:  Larry K Kociolek; Dale N Gerding; Robyn O Espinosa; Sameer J Patel; Stanford T Shulman; Egon A Ozer
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

8.  Potential causative agents of acute gastroenteritis in households with preschool children: prevalence, risk factors, clinical relevance and household transmission.

Authors:  M Heusinkveld; L Mughini-Gras; R Pijnacker; H Vennema; R Scholts; K W van Huisstede-Vlaanderen; T Kortbeek; M Kooistra-Smid; W van Pelt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-02       Impact factor: 3.267

9.  Clostridium difficile in paediatric populations.

Authors:  Upton D Allen
Journal:  Paediatr Child Health       Date:  2014-01       Impact factor: 2.253

10.  Healthcare-associated Clostridium difficile infection: role of correct hand hygiene in cross-infection control.

Authors:  R Ragusa; G Giorgianni; L Lupo; A Sciacca; S Rametta; M La Verde; S Mulè; M Marranzano
Journal:  J Prev Med Hyg       Date:  2018-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.